The combination of sulfasalazine, an ferroptosis inducer targeting SLC7A11, and IR enhanced the sensitivity of cancer cells to radiotherapy, synergistically induced ferroptosis, and significantly inhibited tumor growth (120, 169). This evidence concerns the gene SLC7A11 and cancer.